1. CLS reported Q1 earnings exceeding expectations with $2.65 billion revenue. 2. Adjusted EPS was $1.20, surpassing estimates of $1.15 per share. 3. Second-quarter revenue guidance lower than estimates, impacting investor sentiment. 4. Full-year 2025 guidance raised, but still below analyst expectations. 5. Shares fell 3.3% to $86.13 despite positive earnings.
While CLS beat EPS and revenue estimates, guidance shortfalls led to a share decline, reflecting caution from investors. Historical cases show stock reactions often hinge on guidance despite positive earnings results.
The article reveals critical earnings figures and forward guidance while indicating analyst opinions, affecting stakeholder decisions.
Immediate buy/sell reactions will be observed due to quarterly earnings; however, long-term trends depend on actual Q2 results and full-year performance against guidance.